PHARMACIA
Scope & Guideline
Unlocking the future of pharmacy through open-access research.
Introduction
Aims and Scopes
- Pharmacological Research and Drug Development:
The journal publishes studies on the discovery and development of new pharmaceutical compounds, including their synthesis, characterization, and evaluation of biological activities. - Clinical Pharmacology and Therapeutics:
Research focusing on the clinical aspects of drug therapy, including efficacy, safety, pharmacokinetics, and pharmacodynamics in various patient populations. - Natural Products and Phytochemistry:
The exploration of natural products for their pharmacological potential, including studies on herbal medicines, phytochemicals, and traditional healing practices. - Formulation Science and Drug Delivery Systems:
Innovations in drug formulation and delivery methods, emphasizing the development of novel drug delivery systems such as nanoparticle-based therapies and transdermal patches. - Public Health and Pharmacoeconomics:
Research addressing public health issues, medication adherence, and economic evaluations of pharmacological interventions to optimize healthcare outcomes. - Regulatory Affairs and Pharmaceutical Legislation:
Studies related to regulatory policies, drug approval processes, and the impact of pharmaceutical legislation on drug accessibility and safety.
Trending and Emerging
- Artificial Intelligence and Machine Learning in Drug Development:
The integration of AI and machine learning methodologies for drug discovery and development, predictive modeling of drug interactions, and optimization of therapeutic strategies is increasingly featured. - Nanotechnology in Medicine:
Research on nanomedicine, including the use of nanoparticles for targeted drug delivery, enhanced bioavailability, and reduced toxicity, is on the rise. - Pharmacogenomics and Personalized Medicine:
Studies examining genetic variations that affect drug metabolism and response, supporting the move towards personalized pharmacotherapy tailored to individual patient profiles. - Telepharmacy and Digital Health Solutions:
The rise of telepharmacy and digital health technologies, especially post-COVID-19, reflects a growing interest in remote patient monitoring and medication management. - Antimicrobial Resistance and Stewardship:
Research addressing the challenges of antimicrobial resistance, including stewardship programs and the development of novel antimicrobials, is increasingly relevant. - Integrative Approaches in Chronic Disease Management:
Emerging studies focus on integrative methods for managing chronic diseases, combining pharmacological treatments with lifestyle interventions and complementary therapies.
Declining or Waning
- Traditional Medicine Studies:
Research related to traditional medicine practices and their efficacy has decreased, possibly due to a shift towards more evidence-based and clinical trial-oriented research. - Chemical Synthesis of Known Compounds:
The focus on the synthesis of already established compounds, rather than novel entities, has waned as the field increasingly prioritizes innovative drug discovery. - Basic Laboratory Studies:
Basic laboratory research without direct clinical implications is less prevalent, as there is a growing demand for studies that translate findings into clinical applications. - Single-Site Clinical Trials:
There has been a noticeable decline in studies that focus on single-site clinical trials, as multi-center and global studies gain preference for their broader applicability and relevance. - In Vitro Studies Without Clinical Correlation:
The number of purely in vitro studies lacking a clear clinical correlation has decreased, as the journal emphasizes research that can demonstrate practical applications in patient care.
Similar Journals
Advances in Pharmacological and Pharmaceutical Sciences
Elevating Pharmacological Knowledge for a Healthier Tomorrow.Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.
Istanbul Journal of Pharmacy
Exploring new frontiers in drug formulation and delivery.Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.
JOURNAL OF PHARMACY AND PHARMACOLOGY
Driving excellence in pharmacy and pharmacological research.Journal of Pharmacy and Pharmacology, published by Oxford University Press, is a prestigious academic journal dedicated to the advancement of knowledge in the fields of pharmaceutical sciences and pharmacology. With a strong heritage dating back to 1949, this journal maintains a robust influence, as evidenced by its ranking in the second quartile (Q2) across both Pharmaceutical Science and Pharmacology categories for 2023. The journal is accessible without an open access option, ensuring traditional academic engagement and providing valuable insights for researchers and professionals. It boasts an impressive Scopus ranking, with a percentile positioning of 72nd in Pharmaceutical Science and 67th in Pharmacology. Aimed at fostering innovative research and facilitating the exchange of cutting-edge scientific knowledge, the Journal of Pharmacy and Pharmacology serves as an essential resource for scientists, students, and healthcare professionals committed to enhancing therapeutic outcomes and advancing pharmaceutical innovations.
Journal of Reports in Pharmaceutical Sciences
Transforming Insights into Impactful Pharmaceutical Solutions.Journal of Reports in Pharmaceutical Sciences is a pivotal publication in the realm of pharmaceutical research, disseminating innovative findings that cater to the evolving landscape of pharmacology, toxicology, and biomedical engineering. Published by Wolters Kluwer Medknow Publications, the journal serves as a bridge for scholars and practitioners aiming to enhance their understanding of drug development, therapeutic advances, and biopharmaceutical technologies. With an ISSN of 2322-1232 and E-ISSN 2322-5106, it has established its relevance from 2012 to 2022, occupying notable quartile rankings, including Q3 in Pharmacology, Toxicology, and Pharmaceutics. Despite being categorized in Q4 in some areas, the journal's commitment to quality research ensures it remains a respected platform for disseminating significant insights. Researchers, professionals, and students alike will find this journal an indispensable resource for staying updated on critical advancements in pharmaceutical sciences, making it a go-to source for impactful studies that shape industry practices and academic inquiries.
Indonesian Journal of Pharmacy
Catalyzing advancements in pharmacy for a sustainable future.Indonesian Journal of Pharmacy (ISSN: 2338-9486; E-ISSN: 2338-9427), published by UNIV GADJAH MADA, FAC FARMASI, stands as a significant platform for disseminating pioneering research in the field of pharmacy and pharmacology. Since its transition to an Open Access format in 2011, the journal has enhanced its visibility and accessibility, catering to a global audience of researchers, practitioners, and students. With a commendable Q3 category ranking in Pharmaceutical Science, Pharmacology, and Pharmacy for 2023, along with its respectable Scopus ranks, it provides valuable insights and advancements in the pharmaceutical sciences, particularly relevant to the Indonesian context and beyond. The journal not only supports the academic community but also contributes to the enhancement of healthcare practices through rigorous peer-reviewed publications. By fostering knowledge exchange and collaboration, the Indonesian Journal of Pharmacy aims to play a pivotal role in advancing research and development in pharmacy-related disciplines.
Egyptian Pharmaceutical Journal
Connecting researchers to the forefront of pharmaceutical advancements.The Egyptian Pharmaceutical Journal, published by Wolters Kluwer Medknow Publications, stands as a vital resource for researchers and practitioners in the fields of pharmaceutical sciences and biotechnology. With an ISSN of 1687-4315 and E-ISSN of 2090-9853, this journal disseminates high-quality, peer-reviewed research that spans a wide array of topics including pharmacology, toxicology, and biochemistry. Despite its emerging status, as reflected in its current Q4 and Q3 quartile rankings across various categories, the journal plays a significant role in contributing to the academic dialogue and promoting innovative findings within the scientific community. Operating from India, the journal is committed to open access principles, ensuring that cutting-edge research is readily available to a global audience. As the journal continues to evolve from its 2019 to 2024 convergence period, it aims to further enhance its impact factor and broaden its scope in the interdisciplinary domains of pharmaceutical sciences. Whether you are a student exploring new frontiers or a seasoned researcher aiming to publish your findings, The Egyptian Pharmaceutical Journal remains a dynamic platform for advancement in your field.
Turkish Journal of Pharmaceutical Sciences
Fostering Collaboration in Pharmaceutical InnovationThe Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.
FARMACIA
Advancing Pharmaceutical Knowledge, One Article at a Time.FARMACIA is a renowned academic journal published by the SOC STIINTE FARMACEUTICE ROMANIA, specializing in the field of pharmacology, toxicology, and pharmaceutics. With a rich history dating back to its initial publication years of 1945 to 1946, and ongoing contributions since 2008, the journal has established itself as a significant platform for disseminating cutting-edge research in the pharmaceutical sciences. Indexed in Scopus, it holds a commendable Q2 ranking in the Pharmacology, Toxicology and Pharmaceutics category, reflecting its importance in the field. The journal aims to foster knowledge sharing and innovation among researchers, professionals, and students alike, making it an essential resource for advancing pharmaceutical research. Although it does not currently offer Open Access, the content is accessible to a broad academic audience, ensuring valuable insights into current trends and discoveries in pharmacotherapy and drug development. For those seeking a deeper understanding of the evolving landscape of pharmaceutical sciences, FARMACIA provides a critical lens through which to explore and engage with the latest scientific advancements.
International Journal of Pharmacology
Exploring the Depths of Drug Actions and InteractionsWelcome to the International Journal of Pharmacology, a key publication in the field of pharmacology, published by ASIAN NETWORK SCIENTIFIC INFORMATION (ANSINET). Since its inception in 2006, this journal has provided a vital platform for researchers and professionals to disseminate their findings and insights in pharmacology, toxicology, and pharmaceutics. Despite recent discontinuation in Scopus coverage, the journal's dedication to fostering scientific dialogue continues to attract contributions from esteemed scholars globally. With an **ISSN of 1811-7775** and **E-ISSN of 1812-5700**, the journal seeks to bridge the gap between laboratory research and clinical application, promoting a deeper understanding of drug actions and interactions. Although it operates under traditional access options, the relevance of its published studies to ongoing pharmacological research remains significant.
Pharmaceutical Sciences
Empowering global health through cutting-edge pharmaceutical research.Pharmaceutical Sciences, an esteemed journal published by Tabriz University of Medical Sciences, Faculty of Pharmacy, serves as a crucial platform for the dissemination of pioneering research in the fields of pharmaceutical science, pharmacology, and toxicology. With an impact factor reflective of its substantial contribution to the scientific community, this open access journal has been accessible since 2012, ensuring that researchers, professionals, and students worldwide can engage with its rich content. Located in Iran, it has continually evolved, covering research from 2009 to 2024, and boasts impressive rankings in multiple Scopus categories, including Q3 in Pharmaceutical Science and Q2 in Pharmacology, Toxicology and Pharmaceutics. By bridging gaps between scientific inquiry and practical applications, Pharmaceutical Sciences is dedicated to advancing pharmaceutical knowledge and promoting innovative practices that address significant health challenges.